What are the advantages of stem cell therapy for diabetes

Stem cells are primitive cells with the potential for self-replication and multi-directional differentiation. Under certain conditions, it can differentiate into a variety of functional cells or tissues and organs, and the medical community calls it a "universal cell". When there is a problem somewhere in the body, the energetic stem cells injected into the body will accumulate there to complete the repair function.

There are three types of this:

1. Use good cells to replace damaged cells;

2. Make the damaged cells become healthy cells with sound function;

3. Wake up and activate healthy cells that have not yet worked, so that they can function normally.

Stem cell diabetes has the ability to regenerate and repair pancreatic islet cells, increase the secretion of insulin in the body, inhibit the rising trend of blood sugar, reduce blood sugar indicators, increase the sensitivity of intracellular glycoprotein, promote the combination of pancreatic islet receptors and insulin, and reduce the resistance of insulin, so as to achieve the purpose of diabetes.

Long-term diabetes can lead to complications such as peripheral nerve and vascular diseases, retinopathy, kidney disease, podiatry, etc., and the key to prevention is to control blood sugar within a reasonable range by improving lifestyle and drug standardization**diabetes. In addition, mesenchymal stem cells** also play a role. This kind of primitive cell with self-replication and multi-directional differentiation potential is the origin cell of the body, and theoretically can be the primitive cell of various tissues and organs of the human body.

The human body relies on the proliferation of stem cells and the programmed death of cells to control the dynamic balance of cells in the body, and to carry out the replacement of new and old cells, and the ability to renew cells in the body reflects the health status and vitality of the body. Because stem cells are the origin cells of all cells, and their proliferation and differentiation are important mechanisms for maintaining the homeostasis of cells in the body, timely injection of stem cells will improve the ability of cells in the whole body to renew cells, enhance cell activity, and comprehensively improve the function of tissues and organs. However, before going to Japan**, the hospital needs to do a comprehensive analysis and evaluation of the patient's disease, analyze whether the patient is suitable for this kind of **, and determine whether to accept the patient**, if so, the patient can go through the procedures to make an appointment with the hospital for **.

There are now specialized agencies that contact remote assessments, such as Adventist Health. Hope you find this helpful.

In fact, stem cell research, especially in human diseases, is still in its infancy. For the use of stem cells in diabetes, the top diabetes center in the United States, Joslin Diabetes Center, is still in the exploratory stage. [1]

The Harvard Stem Cell Institute is also exploring the use of stem cells for diabetes, and their goal is to create cells that can sense glucose and produce insulin.

The Diabetes Institute is also conducting research, but the current research is only aimed at determining whether these cells can reverse diabetes in preclinical animal experiments.

According to the National Institutes of Health, although the potential of diabetes stem cells** is huge, routine clinical application is still a futuristic formula.

It can be seen that while researchers are actively studying the potential of stem cells** diabetes, even the top institutions in the United States are only in the exploration stage.

Stem cell ** chaos.

However, some institutions regard this potential as a realistic force, and illegal stem cells are blooming everywhere, even including some stem cell centers set up in tertiary hospitals in China. "Nandu Weekly" had a special ** this kind of chaos in 2012, which focused on stem cell **diabetes**.

In 2012, the Diabetes Branch of the Chinese Medical Association also issued a position statement on stem cell diabetes [6], saying that stem cell diabetes is still in the research stage before clinical application, and stem cell transplantation is not recommended as a routine clinical practice. At the same time, it said that when conducting clinical trials, no fees should be charged to participants in diabetic patients.

And the ** fees of tens of thousands or hundreds of thousands of these institutions at every turn can be said to be well known to everyone in Sima Zhao's heart.

At the same time, stem cells** are also risky.

As a metabolic disease, diabetes has long-term chronic damage to human kidneys, blood vessels, hearts and other organs, and many diabetic patients are also deeply afflicted by it, so they have ardent expectations for diabetes.

Recently, new progress has been made in the field of stem cell diabetes, which either solves the major challenges of stem cell diabetes or improves the safety of stem cell diabetes, which is of great significance for promoting the clinical application of stem cell diabetes.

It is well known that stem cells can be transformed into insulin-producing cells, but there is a significant challenge – the amount of insulin produced by these cells is difficult to control.

In mid-January, researchers at Washington University School of Medicine in St. Louis announced in Stem Cell Reports that they had overcome a major weakness in the previous development of these cells — that they were able to develop insulin-producing cells that are more sensitive to glucose responses.

By adapting the method by which human stem cells induce the production of insulin-secreting cells, the new insulin-producing cells respond more quickly and accurately when confronted with glucose.

What's even more exciting is that when these cells are transplanted into diabetic mice with suppressed immune systems, not only will they not reject somatic cells, but they can also effectively control blood sugar, functionally reducing diabetes in model animals.

Scientists say they will ramp up to an industrial scale to create a large number of these cells that are more sensitive to blood sugar levels and advance the clinical development of stem cell diabetes.

In another study, published in Stem Cell Reports, researchers addressed the limitations of pluripotent stem cell-derived insulin-producing cells, opening a new door to the development of safe cell replacement** for type I diabetes. Researchers can make all the cells derived from pluripotent stem cells be the cells required for diabetes, without generating other redundant, useless or even adversely affected cells.

Addressing the shortage of insulin-producing cells will be one of the main challenges that hinder bio-diabetes. These two recent studies provide a breakthrough in addressing this major challenge. It is conceivable that in the future, stem cells can be used to produce more efficient and safe insulin-producing cells, which is a key step for diabetes stem cells.

Duomu Health also believes that in the near future, diabetes will also be overcome.